A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/102
A61K 47/00 (2006.01) A61K 9/70 (2006.01) A61K 31/40 (2006.01) A61K 31/635 (2006.01) A61K 47/14 (2006.01) A61K 47/18 (2006.01)
Patent
CA 1306677
Abstract of the disclosure: A description is given of a composition for transdermal therapeutic systems, which contains as active compound furosemide, piretanide or lemidosul, or a physiologically tolerated salt of these loop diuretics, in a base composed of a fatty acid alkanolamide, or of a fatty acid alkanol- amide mixture, having 8-18 carbon atoms in the fatty acid residue and 2 to 6 carbon atoms and 1 to 3 hydroxyl groups in the alkanolamide residue, and, where appropriate, of a carboxylic ester, or of a carboxylic ester mixture, in each case having 1-22 carbon atoms in the carboxylic acid moiety and 1-22 carbon atoms in the alcohol moiety.
538049
Hropot Max
Petri Walter
Reul Bernhard
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Aktiengesellschaft
Hropot Max
Petri Walter
Reul Bernhard
LandOfFree
Composition for transdermal therapeutic systems of loop... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for transdermal therapeutic systems of loop..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for transdermal therapeutic systems of loop... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1247768